| with fusion | without fusion | P |
---|---|---|---|
n | 35 | 95 | Â |
Age (years) | 58.5 | 62.8 | 0.050 |
gender | Â | Â | Â |
   male | 14 | 47 | 0.337 |
   female | 21 | 48 |  |
smoking | Â | Â | Â |
   never | 25 | 41 | 0.004 |
   ever | 10 | 54 |  |
pStage | Â | Â | Â |
   I | 20 | 60 | 0.532 |
   II-IV | 15 | 35 |  |
differentiation grade | Â | Â | Â |
   wel | 4 | 44 | <0.001 |
   mod+por | 31 | 51 |  |
Predominant subtype | Â | Â | Â |
   papillary | 21 | 77 | 0.019 |
   Acinar | 13 | 13 |  |
   Bronchioloalveolar | 0 | 4 |  |
   solid with mucin | 0 | 1 |  |
   signet | 1 | 0 |  |
lymphatic invasion | Â | Â | Â |
   - | 24 | 68 | 0.738 |
   + | 11 | 27 |  |
Vessel invasion | Â | Â | Â |
   - | 15 | 51 | 0.273 |
   + | 20 | 44 |  |
TP53 mutation | Â | Â | Â |
   - | 34 | 75 | 0.014 |
   + | 1 | 20 |  |
EGFR mutation | Â | Â | Â |
   - | 35 | 40 | <0.0001 |
   + | 0 | 55 |  |
KRAS mutation | Â | Â | Â |
   - | 35 | 88 | 0.189 |
   + | 0 | 7 |  |